LXRα agonist 1
LXRα agonist 1 is a selective LXRα agonist, with EC50 values of 42 nM and 266 nM against purified LXRα and LXRβ, respectively. LXRα agonist 1 acts as a lipotoxicity inducer, triggering the production of toxic saturated fatty acids in tumor cells, and induces lipotoxicity-mediated cancer cell death when combined with the Raf inhibitor Sorafenib (HY-10201). LXRα agonist 1 can be used in the research of hepatocellular carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 1790089-97-2
- Formula: C28H27N3O2
- Molecular Weight:437.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
LXRα 42 nM (EC50) |
LXRβ 266 nM (EC50) |
In Vitro
LXRα agonist 1 (1-5 μM; 5 d) does not reduce the viability of mouse Akt1Myr; MycOE liver cancer organoids, but it exerts significant anti-tumor activity when combined with 4 μM Sorafenib[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1790089-97-2
-
Molecular Weight 437.53
-
Formula C28H27N3O2
-
SMILES
O=C(C(C1=CC=CC=C1)=C2NC3=CC=C(N4CCCCC4)C=C3)N(CC5=CC=CC=C5)C2=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)